ArticleCancer discovery2024

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.

Andreas Varkaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.